MCC finds no additional benefit for digital mammo

The Michigan Cancer Consortium (MCC) has concluded that there is insufficient data to prove that digital mammography is superior to standard film-screen mammography. The Lansing, MI-based statewide partnership of 80 private and public organizations said it based its opinion on a review of recent digital mammography research by 12 MCC breast cancer experts.

As results from the National Cancer Institute-sponsored Digital Mammographic Imaging Screening Trial (DMIST) will not be available until 2004 or 2005, MCC co-chair Vicki Rakowski said it cannot yet be determined if there is an additional benefit to women from digital screenings or an improvement in the accuracy of breast cancer detection.

Until future evidence emerges to the contrary, film-screen mammography will remain the method of choice for breast cancer screening, said MCC co-chair Dr. Max Wicha. MCC has prepared two position papers on this topic, one for consumers and one for providers. The papers are available at http://consumers.michigancancer.org.

By AuntMinnie.com staff writers
June 11, 2003

Related Reading

Shift to full-field digital units will spur mammography market, April 30, 2003

Key variables impact accuracy of digital mammography, April 21, 2003

Study examines factors that affect FFDM performance, January 10, 2003

No compromise in breast image quality with lower FFDM dose, December 13, 2002

FFDM fares as well as screen-film for population-based breast screening, December 1, 2002

U.S. to fund multicenter digital mammography study, September 5, 2001

Copyright © 2003 AuntMinnie.com

Page 1 of 569
Next Page